Prostate cancer, malignant (ICD10 C61)

Five-year relative survival by HSE area of residence and age at diagnosis (2003-2007 diagnosis period)

	Five-year relative survival (with 95% confidence interval) by HSE area of residence (2003-2007)
Age at diagnosis	Total	Dublin /	Dublin /	South	West
		Mid Leinster	North East
all 15-99	92.8%	95.4%	92.8%	90.8%	91.6%
(unstandardized)	(91.5-94.0%)	(93.0-97.7%)	(89.8-95.6%)	(88.2-93.2%)	(88.8-94.0%)
all 15-99	89.9%	91.7%	87.9%	87.7%	89.0%
(age-standardized)#	(86.7-92.8%)	(85.5-97.6%)	(80.0-94.8%)	(81.7-93.1%)	(83.1-94.2%)
15-44	95.5%	94.1%	93.5%	95.8%	95.8%
	(93.3-97.2%)	(89.2-97.0%)	(86.4-97.2%)	(91.0-98.4%)	(91.2-98.3%)
45-54	96.8%	98.3%	96.8%	94.2%	95.6%
	(95.3-98.1%)	(96.2-100%)	(93.1-99.4%)	(90.8-96.7%)	(91.8-98.4%)
55-64	93.1%	95.1%	95.5%	91.4%	90.6%
	(91.2-94.9%)	(91.3-98.3%)	(91.2-99.1%)	(87.5-94.8%)	(86.6-94.1%)
65-74	82.4%	88.9%	72.1%	78.8%	83.9%
	(78.1-86.5%)	(80.3-96.7%)	(61.2-82.4%)	(70.5-86.7%)	(76.5-90.9%)
75-99	57.9%	52.9%	59.4%	53.9%	54.0%
	(45.2-71.7%)	(23.9-91.1%)	(32.8-89.6%)	(34.8-75.8%)	(33.7-77.7%)

Footnotes:

# Age-standardized figures (presented for the more common cancers) use the standard patient population proposed for this cancer by:

Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316.

(Population weights = age 15-54 x19000, 55-64 x23000, 65-74 x29000, 75-84 x239000, 85-99 x6000; note age-ranges used for this cancer differ from most other cancers)

Exclusions (as in EUROCARE):

Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; second or subsequent malignancies in the same patient

(or the less serious of two or more synchronously-diagnosed malignancies); in situ carcinomas and tumours of uncertain behaviour.

© National Cancer Registry Ireland 2011 (October 2011)  Relative survival statistics for Irish cancer patients